← Leaderboards
Richard Brott Halberg
University Of Wisconsin-Madison
$4,339,402
Attributed
$6,709,652
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,975,550 · 7
By mechanism
U54$8,739,249 · 3
R01$4,723,803 · 2
R21$350,252 · 1
P30$162,246 · 1
Top collaborators
- William M Grady15 shared
- Neelendu Dey9 shared
- Perry Pickhardt6 shared
- Gregory Dean Kennedy2 shared
- William Schelman2 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Perry Pickhardt$2,815,783
- Kristina A. Matkowskyj$1,388,821
- Gregory Dean Kennedy$3,763,279
- William Schelman$116,751
- Howard H Bailey$243,947
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsAdenomaMutationCancer EtiologyColonMolecularColorectal CancerResearch PersonnelMouse ModelTissuesInnovationAffectEpithelial CellsCellsCessation Of LifeTechnologyInterestBiological MarkersTumorBehaviorLesionMissionTranslational ResearchCancer Genetics
Grant awards (33)
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$1,579,708
U54 · FY2025 · CA
Features of the early adenoma and adjacent colon that drive progression: the role of mutation burden in normal tissue, senescent cells, and tumor clonal architecture$315,942
U54 · FY2025 · CA · contact PI
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$255,000
U54 · FY2025 · CA
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$100,184
U54 · FY2025 · CA
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$1,577,081
U54 · FY2024 · CA
Features of the early adenoma and adjacent colon that drive progression: the role of mutation burden in normal tissue, senescent cells, and tumor clonal architecture$455,640
U54 · FY2024 · CA · contact PI
Spatially Informed Malignancy Signatures for Colon Adenomas$178,226
U54 · FY2024 · CA
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$100,184
U54 · FY2024 · CA
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$1,607,986
U54 · FY2023 · CA
Features of the early adenoma and adjacent colon that drive progression: the role of mutation burden in normal tissue, senescent cells, and tumor clonal architecture$311,475
U54 · FY2023 · CA · contact PI
High-resolution mutational landscape of the primed colon in early onset colorectal cancer$174,911
U54 · FY2023 · CA
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$1,692,618
U54 · FY2022 · CA
Features of the early adenoma and adjacent colon that drive progression: the role of mutation burden in normal tissue, senescent cells, and tumor clonal architecture$390,294
U54 · FY2022 · CA · contact PI
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.$491,493
R01 · FY2021 · CA
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.$53,196
R01 · FY2021 · CA
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.$544,256
R01 · FY2020 · CA
Experimental Pathology Laboratory Shared Resource$49,923
P30 · FY2020 · CA · contact PI
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.$678,173
R01 · FY2019 · CA
Experimental Pathology Laboratory Shared Resource$49,927
P30 · FY2019 · CA · contact PI
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.$698,964
R01 · FY2018 · CA
Experimental Pathology Laboratory Shared Resource$42,020
P30 · FY2018 · CA · contact PI
Experimental Pathology Laboratory Shared Resource$10,869
P30 · FY2018 · CA · contact PI
Experimental Pathology Laboratory Shared Resource$5,924
P30 · FY2018 · CA · contact PI
Experimental Pathology Laboratory Shared Resource$3,292
P30 · FY2018 · CA · contact PI
Experimental Pathology Laboratory Shared Resource$291
P30 · FY2018 · CA · contact PI
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.$739,041
R01 · FY2017 · CA
Polyclonal Intestinal Tumors: Formation, Progression, and Significance$280,961
R01 · FY2013 · CA · contact PI
Molecular Differences Predicting Tumor Progression in Colorectal Cancer (PQ #14)$153,849
R21 · FY2013 · CA · contact PI
Polyclonal Intestinal Tumors: Formation, Progression, and Significance$298,894
R01 · FY2012 · CA · contact PI
Molecular Differences Predicting Tumor Progression in Colorectal Cancer (PQ #14)$196,403
R21 · FY2012 · CA · contact PI
Polyclonal Intestinal Tumors: Formation, Progression, and Significance$298,894
R01 · FY2011 · CA · contact PI
Polyclonal Intestinal Tumors: Formation, Progression, and Significance$331,793
R01 · FY2010 · CA · contact PI
Polyclonal Intestinal Tumors: Formation, Progression, and Significance$308,138
R01 · FY2009 · CA · contact PI